Brazil is the only country that has publicly announced plans to buy COVAXIN doses from India. Bharat Biotech has applied for a human trial for its Covid-19 vaccine Covaxin in Bangladesh, as per a Reuters report. Apart from Bangladesh, Brazil is seeking to procure Covaxin for its private market. If the authority in Bangladesh gives … Read more
India Covid-19 Vaccination Update: The Government of India is procuring 110 lakh doses of Covishield from the Serum Institute of India at the cost of 200 per dose. (IE image) India Covid-19 Vaccination Update: India has begun transportation of Covid vaccines – Covishield and Covaxin- ahead of the World’s biggest vaccination drive. While transportation of … Read more
“My deep appreciation to all the volunteers for reposing trust and expressing Pro Vaccine Public Health Volunteerism in Phase 3 clinical Trial of India’s first fully indigenous Covid-19 vaccine. Thank You India,” Suchitra Ella, Joint Managing Director, Bharat Biotech International Limited said. Bharat Biotech has successfully completed the enrolment of 25,800 volunteers for Phase 3 … Read more
Covaxin news, update: On January 3, the Ministry of Health and Family Welfare announced that Emergency Use Authorization (EUA) has been granted to Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin. With approvals of two Covid-19 vaccines—Covaxin (Bharat Biotech) and Covishield (Serum Institute-Oxford), India is all set to begin one of the world’s biggest … Read more
The Phase III efficacy trial of Covaxin was initiated in India in 25,800 volunteers and till date, around 22,500 participants have been vaccinated across the country and the vaccine has been found to be safe as per the data available till date, the Ministry of Health and Family Welfare said in a statement. Covid vaccine … Read more
Anil Vij also tweeted that he has offered to become the first volunteer to be vaccinated for the same. Coronavirus Covid-19 vaccine Covaxin Phase 3 trial in India: Haryana Health Minister Anil Vij has offered himself as the “first volunteer” for the Phase 3 human trials of India’s first indigenous Coronavirus Vaccine candidate Covaxin. Vij … Read more